ELUTIA INC (ELUT)
(Delayed Data from NSDQ)
$1.09 USD
+0.01 (0.93%)
Updated Sep 19, 2025 03:59 PM ET
After-Market: $1.08 -0.01 (-0.92%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth A Momentum F VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
ELUT 1.09 +0.01(0.93%)
Will ELUT be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for ELUT based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for ELUT
Down 25.9% in 4 Weeks, Here's Why ELUTIA INC (ELUT) Looks Ripe for a Turnaround
All You Need to Know About ELUTIA INC (ELUT) Rating Upgrade to Buy
ELUT: What are Zacks experts saying now?
Zacks Private Portfolio Services
Are Medical Stocks Lagging ELUTIA INC (ELUT) This Year?
Other News for ELUT
Is ELUT positioned for a breakdown? New 52 Week Low shows up after gaining 0.93%
ELUT makes New 52 Week Closing Low on September 18
New 52 Week Closing Low appears for ELUT after 4.24% move
Is ELUT building bearish momentum? New 52 Week Closing Low shows up after slipping 3.28%
Elutia (ELUT) Publishes Promising Data on Innovative CIED Biologic Envelope